Summary Allelotypic detection of loss of heterozygosity (LOH) 
Cytogenetic and molecular biology studies of human tumours have identified chromosomal abnormalities, including deletions of specific regions, that are associated with malignancy. Many deletions are believed to involve loss of tumoursuppressor genes, only a few of which have been cloned and sequenced. In the tumour cell, mutation of a tumoursuppressor gene is frequently accompanied by loss of the other non-mutated allele together with portions of adjacent DNA (Solomon et al., 1991) . This DNA loss may be detected using polymorphic markers for the affected locus and, where a marker is informative, deletion of the locus on one chromosome leads to loss of heterozygosity (LOH) for the polymorphism. Analysis of LOH in tumours may be used to indicate the chromosomal location of putative tumoursuppressor genes.
Cytogenetic studies of cervical carcinoma show a high degree of karyotypic variability, although the breakpoints involved in the structural rearrangements are non-randomly distributed (Atkin et al., 1990) . Numerical changes together with non-random deletions, inversions, isochromosome formation and translocations are found to frequently involve chromosome 11. The breakpoints here tended to cluster around the locus llq23-q25 (Sreekantaiah et al., 1991) . LOH has been identified at a number of loci in cervical cancer. Deletion mapping has shown loss at chromosome 3pl3-pl4.3 in 75% (Jones and Nakamura, 1992 ) and 3pl4-p21 in 100% (Yokota et al., 1989) of small series of cervical carcinomas, with a suggestion of LOH at a locus mapping to chromosome l7pl3 (Russell et al., 1992) . Restriction fragment length polymorphism (RFLP) studies using probes that detect different polymorphisms have shown a somatic loss of chromosome 11 heterozygosity in 30% of primary cervical tumours (Srivatsan et al., 1991) . Preliminary data from this laboratory (Bethwaite et al., 1994) and others (Hampton et al., 1994) have demonstrated a high frequency of LOH (43-52%) at loci mapping to 1lq23 in cervical tumours by RFLP and microsatellite polymerase chain reaction (PCR) analysis.
LOH has been identified at an anonymous DlIS29 locus on chromosome llq23 in a proportion of breast cancers (60%) (Stickland et al., 1992) and cutaneous malignant melanomas (67%) (Tomlinson et al., 1993) . The 1 1q23 region is of special interest in human oncogenesis, being frequently altered in haematological malignancies, colorectal tumours and ovarian cancer. Previously undertaken RFLP analysis using probes for DlIS29 was hampered by low rate of informativeness (Stickland et al., 1992; Tomlinson et al., 1993) . However this situation is greatly improved by the identification of a highly polymorphic (GT)" microsatellite variable number of tandem repeats (VNTR) within the locus (Warnich et al., 1992 DNA hybridisation A subsample of cases were rerun on 12% non-denaturing polyacrylamide gels and electrotransferred to charged nylon membrane (Hybond-N+, Amersham) followed by UV light fixing. The membranes were hybridised with a (CA)n nucleotide repeat probe (Quick-Light probe, FMC) and the products detected using a non-isotopic chemiluminescent system (Quick-Light, FMC) on X-ray film.
Results
PCR technique PCR was performed using oligonucleotide primers flanking an informative (GT), microsatellite polymorphism at Dl S29 (Warnich et al., 1992) . Reaction volumes were 50 pl and the reaction constituents are given in Table I and Cl are the values derived from the shorter length allele peak and T2 and C2 from the longer length peak. A priori, a relative ratio of less than 0.50 was chosen as indicative of LOH, based on previous studies (Cawkwell et al., 1993; Orphanos et al., 1993; Hampton et al., 1994) .
Informative cases identified as having LOH at Dl S29 were subject to further analysis using other informative microsatellite dinucleotide polymorphisms at loci on 1 1q13 (DllS534) (Hauge et al., 1991) and llpl2-pll.2 (DllS554) (Phromchotikul et al., 1992) . The PCR approach was similar; the reaction conditions are given in Table I computerised densitometry analysis. Using a relative allelic ratio of less than 0.5 as a cut-off, 9/14 cases were categorised as LOH. Therefore LOH at Dl 1S29 occurred in 25/62 (40%) invasive cervical carcinomas.
Further allelic mapping of these 25 cases using the microsatellite polymorphisms at Dl 1S554 (1 lpl2-pl 1.2) and DllS534 (1 1q13) gave informative results in 22/25 (88%) and 23/25 (92%) respectively. The LOH mapping obtained is summarised in Figure 3 (Cawkwell et al., 1993) . These are short tandem repeat sequences exhibiting length polymorphisms which occur throughout the genome and which are highly informative. This study demonstrates that PCR analysis of microsatellite polymorphisms is easily --applied to routine paraffin-embedded archival material to provide rapid and sensitive detection of allelic imbalance. Allelic imbalance in tumour tissue is a useful marker for putative allelic loss, although as extracted DNA is not quantified the method does not distinguish allelic deletions from mitotic recombination and allele amplification (Nordenskjold, 1990) .
Traditionally, molecular analysis on archival material has involved chemical genomic DNA extractions from whole tissue sections, which often included invasive and in situ tumour tissue together with a variable proportion of constitutional tissue. In addition to obtaining widely varying amounts of DNA from case to case, histological correlations were limited and interpretation of allelic imbalance was subjective. In order to circumvent these problems a range of microdissection techniques have been developed, which allow the selective identification and molecular analysis of cells of interest (Whetsell et al., 1992; Lakhani et al., 1994; Pan et al., 1994) . The modified microdissection technique used in this study was easy and cheap to apply after a short learning period. A 22 gauge syringe needle was found to be as useful and as easy to manipulate as the micropipettes described by Pan et al. (1994) . Dissection under a drop of 50% alcohol prevented any flaking and dispersion of tissue and at the same time allowed the dissected tissue to clump and be easily lifted from the slide. The major advantage of the technique was the reduction in 'contamination' of tumour tissue by constitutional cells, hence giving a largely clean pattern of allelic loss in most instances.
Scoring of allelic loss using microsatellites is often undertaken using radiographic techniques. However, a problem with employing dinucleotide repeat polymorphisms is the production of so-called 'stutter bands' caused by slippage of the Taq polymerase in the PCR resulting in production of smaller fragments and making autoradiographs difficult to interpret. However, in the current study, by using a combination of careful optimisation of PCR reaction conditions, very small quantities of PCR primers in each reaction and employing a 'touchdown' PCR technique, we found that 'stutter bands' were minimised and that scoring was possible following ethidium bromide staining alone.
This study adds to our preliminary report (Bethwaite et al., 1994) , the first to report allelic loss at locus DI1IS29 in human cervical carcinoma, 40% of the cases studied showing loss at this locus. We have made the conservative assumption that additional LOH demonstrated using markers for other loci on llp and/or 1 lq indicate more general loss of a whole or hemichromosome 11, and therefore these cases have been excluded from further analysis. There is support for this assumption using data from RFLP deletion mapping studies (Srivatsan et al., 1991) and from cytogenetic studies of cervical carcinoma which find such patterns of chromosomal 11 loss in between 10% and 30% of tumours (Atkin et al., 1990; Sreekantaiah et al., 1991) . After exclusion of these cases, allelic loss at locus Dl1S29 occurred in 30% of cervical tumours in our hands.
Despite cytogenetic data showing chromosome 11 to be over-represented in structural aberrations in cervical malignancy, there has been little previous work looking at the molecular changes on chromosome 11. Srivatsan et al. (1991) using RFLP analysis on 15 cases of cervical carcinoma found a diversity of loci deleted in six tumour samples, the majority at sites on 1 lq, leading the authors to implicate the long arm as a putative location for a cervical cancer tumour-suppressor gene. Hampton et al. (1994) reported on an allelic mapping study of 32 cervical carcinomas using polymorphic markers, the majority being PCR-detected microsatellite polymorphisms on chromosome 11. This study found evidence of clonal LOH for one or more markers on 1 lq in 14 cases; the highest frequencies were observed with polymorphic loci at the Dl1IS144 locus (52%) and the APOC3 gene (43%), both of which map to 1Iq23. Foulkes et al. (1993) , using microsatellite polymorphisms, produced a deletion map of chromosome 1 lq in 28 epithelial ovarian tumours. At the Dl S29 locus they found LOH in 7 of 15 cases (47%). Interestingly, this study found a higher rate of LOH at adjacent more distal loci, implying that the area of maximum interest for a putative tumour-suppressor gene is distal to the CD3D locus on 1 Iq23.3, which is some 1.8 cM distal from the Dl 1S29 locus. 1 1q23 has also been of importance in haematological malignancies, with rearrangements of this band being very common in acute leukaemias. Here a number of translocations of the MLL gene (also known as the ALL] or HRX gene) from l1q23 lead to the creation of a fusion gene which encodes chimaeric oncogenic proteins (Rowley, 1993) . The role of 1 1q23 in protooncogene activation in cervical malignancy remains to be investigated.
How the existence of a tumour-suppressor gene on human chromosome 1 Iq fits into our current understanding of the aetiology of cervical carcinoma is uncertain. It is known that transfer of a single human chromosome 11 to either the HeLa (Saxon et al., 1986) or SiHa (Koi et al., 1989) cervical carcinoma cell lines suppresses the tumorigenic phenotype. It is now appreciated that several subtypes of human papillomavirus (HPV) occur frequently in cervical carcinoma and its precursor lesions, and that viral integration into host DNA affecting viral early (E) or late protein-encoding regions appears important in the oncogenic process (Lane and Wells, 1994) . Compared with many other tumour types, inactivation of the p53 gene by allelic loss or mutation is an uncommon event in cervical carcinoma, however HPV E6 protein is known to bind to and neutralise normal p53 protein function. HPV integration sites have been shown to be located on chromosomes close to oncogenes, fragile sites and cancer chromosome breakpoints (Cannizzaro et al., 1988) , although chromosome 11 has not been implicated (De Braekeleer et al., 1992) . Interestingly, in experiments on human fibroblast cells co-transfected with an HPV 16 DNA containing plasmid with an activated EJ-ras oncogene, a translocation, t(1:11), was found to be a frequent event; the breakpoint was invariably at 1 1q23 (Matlashewski et al., 1988) . However, in the present series, LOH at Dl 1S29 was not correlated with the presence of HPV as detected by PCR techniques. It is likely that HPV integration is a necessary but not sufficient precondition for cervical cancer, and there is a synergistic role for other oncogenes including c-myc and H-ras (Chen and Defendi, 1992) . Loss or inactivation of putative tumour-suppressor genes on chromosomes 3p (Yokota et al., 1989; Jones and Nakamura, 1992) and 17p (Russell et al., 1992) has been reported in a proportion of cervical tumours, and the data from this and other studies suggest that allelic loss in the region 1 lq22-q24 may be implicated in the chain of malignant transformation in the cervix.
In summary, we have shown that loss of heterozygosity at the Dl1S29 locus on human chromosome 1lq23 occurs in 40% of invasive cervical carcinomas. By excluding those cases where LOH is occurring secondarily to loss of a whole chromosome 11 or its long arm, then we find LOH at Dl lS29 in 30% of cervical carcinomas. Previous reports have shown LOH at this site in other tumour types (Stickland et al., 1992; Foulkes et al., 1993; Tomlinson et al., 1993 ) with a high frequency of LOH at 1 Iq22-q24 in small series of ovarian and cervical carcinomas (Foulkes et al., 1993; Hampton et al., 1994) , implicating a candidate tumour-suppressor gene distally on chromosome 1 lq. The findings in the current study, while not providing a detailed deletion map of the 1 lq region, are consistent with the involvement of chromosome llq in cervical carcinogenesis. Further work is now under way to produce a more detailed deletion map using other loci on chromosome 1 1q23 and distal sites in an attempt to pinpoint more accurately the region of interest. In addition, it is important to examine the pattern of loss in high-and low-grade cervical intraepithelial lesions to assess where events on chromosome 11 are acting in the chain of cervical malignant transformation.
